Health

House Passes Bill to Ban Indirect Federal Funding of Abortion

House Passes Bill to Ban Indirect Federal Funding of Abortion

The bill would prohibit government subsidies for healthcare plans that cover abortions.

FDA Approves New Hepatitis C Drugs

FDA Approves New Hepatitis C Drugs

Drug approval could signal new era in Hepatitis C treatment.

CMS Proposal on Disabled Access to Care

CMS Proposal on Disabled Access to Care

Proposal strictly defines home and community-based care.

Europe’s E. coli Outbreak:  The EU Food Safety Regime Under Stress

Europe’s E. coli Outbreak: The EU Food Safety Regime Under Stress

A rare strain of E. coli raises tensions and questions over the EU response.

New Virginia Legislation on the Closure of Abortion Clinics

New Virginia Legislation on the Closure of Abortion Clinics

The law requires abortion clinics to meet stringent standards.

HHS Rescinds Health Care Conscience Provisions

HHS Rescinds Health Care Conscience Provisions

HHS repeals “overly broad” portions of Bush-era regulation.

CPSC Launches Consumer-Driven Online Database for Unsafe Products

CPSC Launches Consumer-Driven Online Database for Unsafe Products

New product safety initiative receives mixed reviews.

MSHA Seeks More Comments on Proposed Coal Miner Health Rule

MSHA Seeks More Comments on Proposed Coal Miner Health Rule

Proposed standards attempt to reduce black lung disease risk.

Senate Committee Considers the Public Health Implications of Fracking

Senate Committee Considers the Public Health Implications of Fracking

Senators debate whether to regulate a drilling process.

Federal Research Center’s New Venture Into Drug Discovery

Federal Research Center’s New Venture Into Drug Discovery

New National Center for Advancing Translational Sciences works with pharmaceutical companies to develop drugs.

Preemption of Vaccine Injury Lawsuits Upheld

Preemption of Vaccine Injury Lawsuits Upheld

The Supreme Court decides that federal statutes preempt state lawsuits over vaccinations.

FDA Grants Hearing on Proposed Withdrawal of Marketing Approval for Avastin

FDA Grants Hearing on Proposed Withdrawal of Marketing Approval for Avastin

The FDA proposes to withdraw approval for a breast cancer treatment, with hearing scheduled for June.